Associate Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine
Gastroenterology
Dr. Timothy M. McCashland, MD
|
|
Give Review
Timothy M. McCashland works in the field of Gastroenterology. He studied medicine at University of Nebraska Medical Center. University of Nebraska Medical Center is a one of the best medicals schools. University of Nebraska Medical Center has a rank of 60 in research and a 4 in primary care He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (AGAF)". Timothy M. McCashland is a published doctor. He published 61 publications, including: 'Toxic megacolon associated with Campylobacter jejuni colitis.'
Publications
- Impact of Anti-Thymocyte Globulin During Immunosuppression Induction in Patients with Hepatitis C After Liver Transplantation.
- Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
- Risk of cytomegalovirus disease in high-risk liver recipients on valganciclovir prophylaxis: A systematic review and meta-analysis.
- Management of liver transplant recipients with recurrent hepatitis C.
- Racial variation in colorectal polyp and tumor location.
- Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
- Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
- Transplantation in the alcoholic patient.
- Retransplantation for recurrent hepatitis C: positive aspects.
- Poor survival after liver retransplantation: is hepatitis C to blame?
- Current use of transjugular intrahepatic portosystemic shunts.
- High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
- Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
- The predictors of the presence of varices in patients with primary sclerosing cholangitis.
- Predictive value of actin-free Gc-globulin in acute liver failure.
- Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study.
- Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
- Hepatitis B in liver transplant recipients.
- Abnormal liver function tests in a liver transplant recipient with hepatitis B virus: Report of a case.
- Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.
- Acute Budd-Chiari syndrome during pregnancy: surgical treatment and orthotopic liver transplantation with successful completion of the pregnancy.
- Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
- Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy.
- Evaluation of reliability in the use of endoscopic terminology.
- Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.
- The North American Study for the Treatment of Refractory Ascites.
- A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.
- Long-term follow-up of the orthotopic liver transplantation patient.
- The American experience with transplantation for acute liver failure.
- Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: differing effects of cyclosporine and FK 506.
- Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation.
- Etiology and outcome for 295 patients with acute liver failure in the United States.
- Long-term follow-up after liver transplantation in patients with hepatic iron overload.
- Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.
- Mortality while awaiting liver retransplantation: predictability of MELD scores.
- Low incidence of intraspousal transmission of hepatitis C virus after liver transplantation.
- Isolated intestinal transplantation for intestinal failure.
- Bacterial endocarditis in patients with chronic liver disease.
- Gender differences in colorectal polyps and tumors.
- Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
- The time and financial impact of training fellows in endoscopy. CORI Research Project. Clinical Outcomes Research Initiative.
- Intestinal transplantation: a single-center experience.
- Attitudes and expectations of 1995 gastroenterology graduates about gastroenterology.
- Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001.
- Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group.
- Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio.
- Hepatitis C: sexually exposed?
- Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.
- Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.
- Spinal epidural abscess in a liver transplant recipient.
- Posttransplantation care: role of the primary care physician versus transplant center.
- Preoperative evaluation of the living related donor in pediatric living related liver transplantation.
- Collagenous enterocolitis: a manifestation of gluten-sensitive enteropathy.
- High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
- Pneumococcal vaccine response in cirrhosis and liver transplantation.
- Toxic megacolon associated with Campylobacter jejuni colitis.
- Rectovesical ectopic varix intraperitoneal hemorrhage with fatal outcome.
- Lymphocytic (microscopic) colitis--an important cause of chronic watery diarrhea.
- Zonal differences in ethanol-induced impairments in hepatic receptor binding.
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
Education
-
University of Nebraska Medical Center -
University of Nebraska College of Medicine
Drug Facts
| NPI NUMBER | 1417908989 | |
| NPPES Provider LastName | MCCASHLAND | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 681988102 | |
| NPPES Provider State | NE | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 3045.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 0.53 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417908989 |
| Last Name Of The Provider | MCCASHLAND |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Renee L. Young, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael B. Jones, MD |
|
Dr. William C. Livingston, DO |
|
Dr. John C. Mitchell, MD |
|
Dr. Thomas R. McGinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shailender Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert T. Kizer, MD |
|
|
Dr. Derrick D. Eichele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol L. Scott, MD |
|
|
Dr. Robert S. Bridge Jr., MD |
|
Savio C. Reddymasu, MB BS
This Doctor is OpenDoctor Recommended.
|